Frontlight ResearchEarly access
Active, not recruitingNo phase
Shoulder RFA Pilot Study
Key facts
- Who runs it
- University of Utah
- Where
- Farmington, Salt Lake City, and South Jordan, United StatesSee the 3 sites
- Trial code
- Status
- Active, not recruiting
- People taking part
- 10 people, planned
- Started
- 7 Feb 2024
- Expected to end
- Dec 2026
- Type of study
- Observational
- Record updated
- 13 April 2026
Who can take part
- Age
- 50 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
Show the full registry criteria (19)Hide the full registry criteria
Who can take part
- ≥50 years old capable of understanding and providing consent in English, and capable of complying with the outcome instruments used
- ≥3 months of shoulder pain refractory to conventional treatment (i.e., physiotherapy, medication, steroid injections)
- Persistent shoulder pain ≥ 4/10 in intensity on a 7-day average
- Shoulder pain refractory to conventional treatment (i.e., physical therapy, oral analgesics, steroid injection)
- Prior consultation with a board-certified orthopedic shoulder surgeon, deemed a non-surgical candidate for the primary diagnosis of glenohumeral joint pain +/- rotator cuff pain
- ≥80% pain relief for at least 30 minutes after a single fluoroscopically-guided block of the sensory branches of the SN, AN, and LPN with 0.5 mL of lidocaine at each nerve
- Scheduled for procedure of interest
Who cannot take part
- Previous partial/total/reverse shoulder arthroplasty. Participants with a history of RTC repair will not be excluded
- Intraarticular or subacromial injection to the study shoulder within 3 months before C-SRFA
- Prior shoulder radiofrequency ablation
- Infection
- Allergy to any medication needed to participate in this study
- Neurologic disorders including radiculopathy, connective tissue/inflammatory joint disease/widespread soft tissue pain disorder
- Severe, uncontrolled psychiatric disorder requiring hospitalization within 6 months
- Uncontrolled bleeding diathesis
- Pregnancy
- Pacemaker, neurostimulator, or other implanted device potentially sensitive to RF energy
- Active Worker's compensation claim, litigation, or other possible reason for secondary gain
- Daily opioid use
Where in United States
- University of Utah, Farmington Health CenterFarmington, United States
- University of Utah Orthopaedic CenterSalt Lake City, United States
- University of Utah South Jordan Health CenterSouth Jordan, United States
About the trial
What the trial wants to find out
Through this prospective, single-arm cohort pilot study, we plan to explore the safety and effectiveness of Shoulder Radiofrequency Ablation (SRFA) in patients with non-operative chronic shoulder pain due to shoulder osteoarthritis with or without rotator cuff tears.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- The Effectiveness of Shoulder Terminal Sensory Articular Nerve Radiofrequency Ablation for Non-surgical Refractory Shoulder Pain Due to Rotator Cuff Pathology and Osteoarthritis; A Prospective Pilot Study
- Record updated
- 13 April 2026